DexCom Inc. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) slipped 7.06% to $455.78 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.42% to 4,659.03 and Dow Jones Industrial Average falling 0.49% to 36,113.62. The stock's fall snapped a two-day winning streak. DexCom Inc. closed $203.67 short of its 52-week high ($659.45), which the company achieved on November 18th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.61% to $168.76, Abbott Laboratories (ABT) fell 2.70% to $129.65, and Medtronic PLC (MDT) fell 0.16% to $108.78. Trading volume (1.1 M) eclipsed its 50-day average volume of 775,198.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 13, 2022.
-MarketWatch Automation
(END) Dow Jones Newswires
January 13, 2022 16:50 ET (21:50 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.